Interestingly, ACC tumor samples with mutations in NOTCH1 and SPEN had no alterations in MYB and MYBL1, suggesting that other genetic events than alterations in MYB/MYBL1 may also play a central role in developing the ACC (32). This evidence concerns the gene MYB and adrenal cortex carcinoma.